Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
Launched by INTERACTIVE RESEARCH AND DEVELOPMENT · Dec 14, 2017
Trial Information
Current as of June 15, 2025
Completed
Keywords
ClinConnect Summary
Hypothesis:
The coverage rate of Penta-3, Measles-1 and Measles-2 in infants in Karachi will improve with:
1. Short text Messaging Service (SMS) reminders
2. Interactive reminders
Aims:
1. To determine if SMS reminders increases timely vaccine coverage rate in infants from Karachi.
2. To determine if Interactive reminders increases the timely vaccine coverage rate in infants from Karachi.
Background and Rationale:
The World Health Organization's (WHO) goal is to protect all people at risk against vaccine-preventable diseases. The availability of vaccines, however, does not mean that a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Child presenting for pentavalent 1- vaccine
- • Caregivers who owned a cellphone or had access to one
- • Caregivers permanently residing in Korangi Town, Karachi
- Exclusion Criteria:
- • Child presenting for a vaccine other than pentavalent -1
- • Caregivers not having access to a cell phone
- • Caregivers residing outside of Korangi or planning to move from the catchment area
About Interactive Research And Development
Interactive Research and Development (IRD) is a dynamic clinical trial sponsor dedicated to advancing medical research through innovative methodologies and collaborative partnerships. With a strong emphasis on patient-centered approaches, IRD specializes in conducting high-quality, ethically sound clinical trials across various therapeutic areas. Leveraging cutting-edge technology and a robust network of experienced professionals, the organization aims to accelerate the development of new treatments while ensuring compliance with regulatory standards. Committed to fostering transparency and integrity, IRD strives to enhance the efficiency of the clinical research process, ultimately improving health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Subhash Chandir, Phd
Principal Investigator
Interactive Research and Development (IRD)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials